Published in J Virol on January 01, 1975
Covalent linkage of a protein to a defined nucleotide sequence at the 5'-terminus of virion and replicative intermediate RNAs of poliovirus. Proc Natl Acad Sci U S A (1977) 8.12
5'-terminal cap structure in eucaryotic messenger ribonucleic acids. Microbiol Rev (1980) 6.14
Sequential transcription of the genes of vesicular stomatitis virus. Proc Natl Acad Sci U S A (1976) 5.88
Transcription and replication of rhabdoviruses. Microbiol Rev (1987) 4.05
Site on the vesicular stomatitis virus genome specifying polyadenylation and the end of the L gene mRNA. J Virol (1980) 2.81
Polycistronic vesicular stomatitis virus RNA transcripts. Proc Natl Acad Sci U S A (1980) 2.16
Giant heterogeneous polyadenylic acid on vesicular stomatitis virus mRNA synthesized in vitro in the presence of S-adenosylhomocysteine. J Virol (1977) 1.80
Amino acid residues within conserved domain VI of the vesicular stomatitis virus large polymerase protein essential for mRNA cap methyltransferase activity. J Virol (2005) 1.69
Transcript initiation and 5'-end modifications are separable events during vesicular stomatitis virus transcription. J Virol (1999) 1.61
Differential synthesis of blocked and unblocked 5'-termini in reovirus mRNA: effect of pyrophosphate and pyrophosphatase. Proc Natl Acad Sci U S A (1976) 1.59
Terminally repeated sequences in the avian sarcoma virus RNA genome. Proc Natl Acad Sci U S A (1977) 1.58
A unique strategy for mRNA cap methylation used by vesicular stomatitis virus. Proc Natl Acad Sci U S A (2006) 1.56
Two methyltransferase activities in the purified virions of vesicular stomatitis virus. J Virol (1977) 1.42
The length and sequence composition of vesicular stomatitis virus intergenic regions affect mRNA levels and the site of transcript initiation. J Virol (1998) 1.37
A single amino acid change in the L-polymerase protein of vesicular stomatitis virus completely abolishes viral mRNA cap methylation. J Virol (2005) 1.36
Sequential synthesis of 5'-proximal vesicular stomatitis virus mRNA sequences. J Virol (1982) 1.24
Identification of a minimal size requirement for termination of vesicular stomatitis virus mRNA: implications for the mechanism of transcription. J Virol (2000) 1.24
Removal of 5'-terminal m7G from eukaryotic mRNAs by potato nucleotide pyrophosphatase and its effect on translation. Nucleic Acids Res (1977) 1.19
Preferential translation of vesicular stomatitis virus mRNAs is conferred by transcription from the viral genome. J Virol (2006) 1.18
In vitro transcription of vesicular stomatitis virus: initiation with GTP at a specific site within the N cistron. J Virol (1982) 1.09
Endoribonuclease activity associated with animal RNA viruses. J Virol (1978) 0.97
Alternate capping mechanisms for transcription of spring viremia of carp virus: evidence for independent mRNA initiation. J Virol (1980) 0.96
Analysis of a structural homology model of the 2'-O-ribose methyltransferase domain within the vesicular stomatitis virus L protein. Virology (2008) 0.95
An unconventional pathway of mRNA cap formation by vesiculoviruses. Virus Res (2011) 0.94
Dinucleotide Sequences at the 5' Ends of Vaccinia Virus mRNA's Synthesized In Vitro. J Virol (1980) 0.90
A freeze frame view of vesicular stomatitis virus transcription defines a minimal length of RNA for 5' processing. PLoS Pathog (2011) 0.90
Aberrant glycoprotein mRNA synthesized by the internal deletion mutant of vesicular stomatitis virus. J Virol (1981) 0.89
5'-terminal sequences of spring viremia of carp virus RNA synthesized in vitro. J Virol (1979) 0.89
New mRNAs are preferentially translated during vesicular stomatitis virus infection. J Virol (2007) 0.85
Identification of sendai virus L protein amino acid residues affecting viral mRNA cap methylation. J Virol (2008) 0.83
Inactivation of influenza and vesicular stomatitis virion RNA polymerase activities by photoreaction with 4'-substituted psoralens. J Virol (1979) 0.82
Capping of vesicular stomatitis virus pre-mRNA is required for accurate selection of transcription stop-start sites and virus propagation. Nucleic Acids Res (2014) 0.81
Synthesis of capped and uncapped methylated oligonucleotides by the virion transcriptase of spring viremia of carp virus, a rhabdovirus. Proc Natl Acad Sci U S A (1981) 0.81
Ribonucleic acid synthesis of vesicular stomatitis virus, II. An RNA polymerase in the virion. Proc Natl Acad Sci U S A (1970) 11.83
Reovirus messenger RNA contains a methylated, blocked 5'-terminal structure: m-7G(5')ppp(5')G-MpCp-. Proc Natl Acad Sci U S A (1975) 6.26
The 5' terminal structure of the methylated mRNA synthesized in vitro by vesicular stomatitis virus. Cell (1975) 4.43
Translation and identification of the mRNA species synthesized in vitro by the virion-associated RNA polymerase of vesicular stomatitis virus. Proc Natl Acad Sci U S A (1975) 4.17
In vitro synthesis of RNA that contains polyadenylate by virion-associated RNA polymerase of vesicular stomatitis virus. Proc Natl Acad Sci U S A (1973) 3.17
Messenger RNA species synthesized in vitro by the virion-associated RNA polymerase of vesicular stomatitis virus. Cell (1975) 3.04
Studies on the in vitro adenylation of RNA by vesicular stomatitis virus. Virology (1974) 2.83
Translation and identification of the viral mRNA species isolated from subcellular fractions of vesicular stomatitis virus-infected cells. J Virol (1975) 2.68
In vitro synthesis of methylated messenger RNA by the virion-associated RNA polymerase of vesicular stomatitis virus. Cell (1974) 2.42
Novel initiation of RNA synthesis in vitro by vesicular stomatitis virus. Nature (1975) 2.36
Methylated and blocked 5' termini in vesicular stomatitis virus in vivo mRNAs. Cell (1975) 2.15
Sub-cellular localization of vesicular stomatitis virus messenger RNAs. Biochem Biophys Res Commun (1975) 1.91
Synthesis of poly(A) in vitro by purified virions of vesicular stomatitis virus. Nat New Biol (1973) 1.83
Isolation and sequence determination of the 3'-terminal regions of isotopically labelled RNA molecules. Nucleic Acids Res (1974) 1.53
RNA transcription by the virion polymerases of five rhabdoviruses. J Virol (1974) 1.52
The isolation of 3'-terminal polynucleotides from RNA molecules. Biochim Biophys Acta (1971) 1.43
Guanosine-5'-diphosphate at the 5' termini of reovirus RNA: evidence for a segmented genome within the virion. J Mol Biol (1971) 1.40
Polyadenylation of vesicular stomatitis virus mRNA. J Virol (1974) 1.39
5'-terminal cap structure in eucaryotic messenger ribonucleic acids. Microbiol Rev (1980) 6.14
Sequential transcription of the genes of vesicular stomatitis virus. Proc Natl Acad Sci U S A (1976) 5.88
Methylation-dependent translation of viral messenger RNAs in vitro. Proc Natl Acad Sci U S A (1975) 5.02
Exclusion of elderly people from clinical research: a descriptive study of published reports. BMJ (1997) 4.95
The 5' terminal structure of the methylated mRNA synthesized in vitro by vesicular stomatitis virus. Cell (1975) 4.43
Translation and identification of the mRNA species synthesized in vitro by the virion-associated RNA polymerase of vesicular stomatitis virus. Proc Natl Acad Sci U S A (1975) 4.17
Transcription and replication of rhabdoviruses. Microbiol Rev (1987) 4.05
A unique RNA species involved in initiation of vesicular stomatitis virus RNA transcription in vitro. Cell (1976) 3.82
Oxygen desaturation during endoscopy in the elderly. J R Coll Physicians Lond (1993) 3.37
In vitro synthesis of RNA that contains polyadenylate by virion-associated RNA polymerase of vesicular stomatitis virus. Proc Natl Acad Sci U S A (1973) 3.17
Transcription in vitro by reovirus-associated ribonucleic acid-dependent polymerase. J Virol (1970) 3.07
Complete nucleotide sequence of the leader RNA synthesized in vitro by vesicular stomatitis virus. Cell (1978) 3.06
Messenger RNA species synthesized in vitro by the virion-associated RNA polymerase of vesicular stomatitis virus. Cell (1975) 3.04
Studies on the in vitro adenylation of RNA by vesicular stomatitis virus. Virology (1974) 2.83
Translation and identification of the viral mRNA species isolated from subcellular fractions of vesicular stomatitis virus-infected cells. J Virol (1975) 2.68
In vitro synthesis of methylated messenger RNA by the virion-associated RNA polymerase of vesicular stomatitis virus. Cell (1974) 2.42
Unique mode of transcription in vitro by Vesicular stomatitis virus. Cell (1980) 2.36
Novel initiation of RNA synthesis in vitro by vesicular stomatitis virus. Nature (1975) 2.36
Rescue of synthetic analogs of genome RNA of human parainfluenza virus type 3. Virology (1993) 2.33
An infectious clone of human parainfluenza virus type 3. J Virol (1997) 2.28
Improving cancer radiotherapy with 2-deoxy-D-glucose: phase I/II clinical trials on human cerebral gliomas. Int J Radiat Oncol Biol Phys (1996) 2.15
Methylated and blocked 5' termini in vesicular stomatitis virus in vivo mRNAs. Cell (1975) 2.15
Phosphorylation by cellular casein kinase II is essential for transcriptional activity of vesicular stomatitis virus phosphoprotein P. Proc Natl Acad Sci U S A (1992) 2.03
Influence of 5'-terminal m7G and 2'--O-methylated residues on messenger ribonucleic acid binding to ribosomes. Biochemistry (1976) 1.99
Phosphorylation within a specific domain of the phosphoprotein of vesicular stomatitis virus regulates transcription in vitro. Cell (1987) 1.92
Intervening polyadenylate sequences in RNA transcripts of vesicular stomatitis virus. Cell (1978) 1.92
Sub-cellular localization of vesicular stomatitis virus messenger RNAs. Biochem Biophys Res Commun (1975) 1.91
Complex formation with vesicular stomatitis virus phosphoprotein NS prevents binding of nucleocapsid protein N to nonspecific RNA. J Virol (1988) 1.91
Sequential phosphorylation of the phosphoprotein of vesicular stomatitis virus by cellular and viral protein kinases is essential for transcription activation. J Virol (1992) 1.88
Identification of a domain within the phosphoprotein of vesicular stomatitis virus that is essential for transcription in vitro. Proc Natl Acad Sci U S A (1986) 1.87
Requirements and functions of vesicular stomatitis virus L and NS proteins in the transcription process in vitro. Biochem Biophys Res Commun (1985) 1.79
Parasitic infections of the lung: a guide for the respiratory physician. Thorax (2010) 1.78
Mapping and initiation studies on the leader RNA of vesicular stomatitis virus. Virology (1977) 1.78
Vesicular stomatitis virus NS proteins: structural similarity without extensive sequence homology. J Virol (1985) 1.73
Transcriptional activity and mutational analysis of recombinant vesicular stomatitis virus RNA polymerase. J Virol (1993) 1.73
Mapping of interacting domains between the nucleocapsid protein and the phosphoprotein of vesicular stomatitis virus by using a two-hybrid system. Proc Natl Acad Sci U S A (1993) 1.63
Initiation of reovirus mRNA synthesis in vitro. Nat New Biol (1971) 1.61
Cloning and expression of the vesicular stomatitis virus phosphoprotein gene in Escherichia coli: analysis of phosphorylation status versus transcriptional activity. J Virol (1991) 1.60
Simultaneous pulmonary and cerebral oedema, and multiple CNS infarctions as complications of diabetic ketoacidosis: a case report. Diabet Med (2006) 1.60
The nature of the RNA products synthesized in vitro by subviral components of visicular stomatitis virus. Virology (1976) 1.60
Resolution of multiple complexes of phosphoprotein NS with nucleocapsid protein N of vesicular stomatitis virus. J Virol (1988) 1.57
Common variable immune deficiency: respiratory manifestations, pulmonary function and high-resolution CT scan findings. QJM (2002) 1.54
In vitro synthesis of messenger RNA by a defective interfering particle of vesicular stomatitis virus. Proc Natl Acad Sci U S A (1977) 1.51
Endoscopic transthoracic sympathectomy in the treatment of hyperhidrosis. Ann Surg (1992) 1.51
RNA polymerase of vesicular stomatitis virus specifically associates with translation elongation factor-1 alphabetagamma for its activity. Proc Natl Acad Sci U S A (1998) 1.49
Does a doctor's dress-style matter? Med J Aust (1988) 1.49
In vitro phosphorylation of NS protein by the L protein of vesicular stomatitis virus. J Gen Virol (1985) 1.48
Complications of parotid surgery: the need for selectivity. Br J Surg (1989) 1.48
RNA editing in the phosphoprotein gene of the human parainfluenza virus type 3. Virology (1992) 1.44
In vitro RNA transcription by the New Jersey serotype of vesicular stomatitis virus. I. Characterization of the mRNA species. J Virol (1978) 1.44
Initiation of RNA synthesis in vitro by vesicular stomatitis virus. Role of ATP. J Biol Chem (1979) 1.43
Replication of RNA viruses. X. Replication of a natural 6 s RNA by the Q-beta RNA polymerase. J Mol Biol (1969) 1.42
Two methyltransferase activities in the purified virions of vesicular stomatitis virus. J Virol (1977) 1.42
Guanosine-5'-diphosphate at the 5' termini of reovirus RNA: evidence for a segmented genome within the virion. J Mol Biol (1971) 1.40
Specific interactions of vesicular stomatitis virus L and NS proteins with heterologous genome ribonucleoprotein template lead to mRNA synthesis in vitro. J Virol (1984) 1.39
Anterior tibial artery embolectomy augmented by dynamic on-table angiography. Lancet (1991) 1.39
Phosphorylation of specific serine residues within the acidic domain of the phosphoprotein of vesicular stomatitis virus regulates transcription in vitro. J Virol (1992) 1.38
Intramedullary spinal cysticercosis. Case report and review of literature. Clin Neurol Neurosurg (1987) 1.38
The life and work of the Birmingham radiologist Dr James Brailsford (1888-1961). J Med Biogr (2004) 1.38
Identification of promoter-proximal oligonucleotides and a unique dinucleotide, pppGpC, from in vitro transcription products of vesicular stomatitis virus. J Virol (1981) 1.38
Communication in surgical practice. J R Soc Med (1987) 1.38
Purified matrix protein of vesicular stomatitis virus blocks viral transcription in vitro. Proc Natl Acad Sci U S A (1982) 1.34
Cellular protein kinase C isoform zeta regulates human parainfluenza virus type 3 replication. Proc Natl Acad Sci U S A (1995) 1.33
Phosphorylation within the amino-terminal acidic domain I of the phosphoprotein of vesicular stomatitis virus is required for transcription but not for replication. J Virol (1997) 1.31
Characterization of the in vitro system for the synthesis of mRNA from human respiratory syncytial virus. Virology (1993) 1.31
The transcription complex of vesicular stomatitis virus. Cell (1987) 1.30
High prevalence of subclinical hypothyroidism during first trimester of pregnancy in North India. Indian J Endocrinol Metab (2013) 1.30
Association of simple anthropometric measures of obesity with visceral fat and the metabolic syndrome in male Caucasian and Indo-Asian subjects. Diabet Med (2004) 1.30
Phosphoprotein NS of vesicular stomatitis virus: phosphorylated states and transcriptional activities of intracellular and virion forms. Virology (1986) 1.29
Specific interaction in vitro and in vivo of glyceraldehyde-3-phosphate dehydrogenase and LA protein with cis-acting RNAs of human parainfluenza virus type 3. J Biol Chem (1996) 1.29
Crohn's or poisoning? Gut (1988) 1.29
In vitro synthesis of the full-length complement of the negative-strand genome RNA of vesicular stomatitis virus. Proc Natl Acad Sci U S A (1980) 1.28
Absence of abdominal pain in elderly patients with peptic ulcer. Age Ageing (1984) 1.27
In vivo methylation of vesicular stomatitis virus and its host-cell messenger RNA species. Virology (1976) 1.27
Messenger RNA encoding the phosphoprotein (P) gene of human parainfluenza virus 3 is bicistronic. Virology (1986) 1.26
Precise mapping of the replication and transcription promoters of human parainfluenza virus type 3. Virology (2000) 1.26
Cytosine at the 3'-termini of reovirus genome and in vitro mRNA. Nat New Biol (1971) 1.25
Studies on the in vivo and in vitro messenger RNA species of vesicular stomatitis virus. Virology (1975) 1.23
Non-steroidal anti-inflammatory drugs and peptic ulceration. J R Coll Physicians Lond (1987) 1.23
Role of cellular actin in human parainfluenza virus type 3 genome transcription. J Biol Chem (1993) 1.22
Sequences of Chandipura virus N and NS genes: evidence for high mutability of the NS gene within vesiculoviruses. Virology (1987) 1.22
NH2-terminal acidic region of the phosphoprotein of vesicular stomatitis virus can be functionally replaced by tubulin. Proc Natl Acad Sci U S A (1988) 1.21
Involvement of actin microfilaments in the replication of human parainfluenza virus type 3. J Virol (1998) 1.21
Percutaneous needle biopsies of renal allografts: the relationship between morphological changes present in biopsies and subsequent allograft function. Histopathology (1977) 1.20
Human parainfluenza virus type 3 transcription in vitro: role of cellular actin in mRNA synthesis. J Virol (1991) 1.20
Characterization of an in vitro system for the synthesis of mRNA from human parainfluenza virus type 3. J Virol (1990) 1.19
Involvement of cellular casein kinase II in the phosphorylation of measles virus P protein: identification of phosphorylation sites. Virology (1995) 1.18
Nucleotide sequence of the leader RNA of the New Jersey serotype of vesicular stomatitis virus. Nucleic Acids Res (1978) 1.18
Seasonal distribution of Vibrio parahaemolyticus in freshwater environs and in association with freshwater fishes in Calcutta. Appl Environ Microbiol (1985) 1.18
Patterns of urine flow and electrolyte excretion in healthy elderly people. Br Med J (Clin Res Ed) (1983) 1.18
The functional domains of the phosphoprotein (NS) of vesicular stomatitis virus (Indiana serotype). Virology (1988) 1.14
Absence of polyadenylic acid from reovirus messenger ribonucleic acid. J Biol Chem (1973) 1.14
Characterization of vesicular stomatitis virus mRNA species synthesized in vitro. J Virol (1977) 1.14